Overview

Open-label Clinical Trial of Lacosamide in ALS

Status:
Completed
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
Lacosamide is administered for patients with amyotrophic lateral sclerosis (ALS).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chiba University
Treatments:
Lacosamide